In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase

Since the outbreak emerged in November 2019, no effective drug has yet been found against SARS-CoV-2. Repositioning studies of existing drug molecules or candidates are gaining in overcoming COVID-19. Antiviral drugs such as remdesivir, favipiravir, ribavirin, and galidesivir act by inhibiting the v...

Descripción completa

Detalles Bibliográficos
Autores principales: Celik, Ismail, Erol, Meryem, Duzgun, Zekeriya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992164/
https://www.ncbi.nlm.nih.gov/pubmed/33765239
http://dx.doi.org/10.1007/s11030-021-10215-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992164/
https://www.ncbi.nlm.nih.gov/pubmed/33765239
http://dx.doi.org/10.1007/s11030-021-10215-5

Ejemplares similares